NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2017

Total Assets: $344.5M

Liabilities Breakdown FY2017

Total Liabilities: $139.9M